United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2004 NY Rulings > NY R00518 - NY R00569 > NY R00557

Previous Ruling Next Ruling
NY R00557




July 19, 2004
CLA-2-30:RR:NC:2:238 R00557

CATEGORY: CLASSIFICATION

TARIFF NO.: 3002.10.0190

Mr. Oscar Lejarraga
Araclon Biotech SL
Calle San Miguel 15, 2B
Zaragoza, Spain 50001

RE: The tariff classification of affinity purified antibodies from Spain

Dear Mr. Lejarraga:

In your letter dated July 9, 2004, you requested a tariff classification ruling.

The subject products, affinity purified antibodies, consist of monospecific antibodies (i.e., antibodies specific for a particular target peptide) isolated/separated from polyclonal antisera by affinity chromatography. You state in your letter that the subject antibodies will be used exclusively in research to detect the presence of the main isoforms of amyloid beta protein in tissue or blood specimens.

The applicable subheading for affinity purified antibodies will be 3002.10.0190, Harmonized Tariff Schedule of the United States (HTS), which provides for “Antisera and other blood fractions and modified immunological products, whether or not obtainied by biotechnological processes: Other.” The rate of duty will be free.

This merchandise may be subject to the rules and regulations of the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, located at 1600 Clifton Rd., Atlanta, GA 30333. You may contact them, by telephone, at: (404)-639-3311.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.

Sincerely,

Robert B. Swierupski

Previous Ruling Next Ruling

See also: